Abstract:By systematically combing the theory of “Shaoyang” in traditional Chinese medicine, it is found that the theory of “Shaoyang” is closely related to the metastasis of colorectal cancer. Physiologically, shaoyang is the pivot of the body, communicating the inside and outside of the body, maintaining the movement of qi, regulating the flow of fluid, blood and emotions. If shaoyang is unfavorable, it will lead to poor communication inside and outside the human body, form the turbid phlegm and blood stasis, disturb qi’s rise and fall, cause emotional disorder and spiritual failure. “Shaoyang” theory can affect the metastasis of colorectal cancer in the following aspects: first, the cancer toxin such as turbid phlegm and blood stasis will be endogenous if Shaoyang qi is not favorable; second, the cancer toxin will be transferred if qi mechanism is not working properly; third, if the Shaoyang cardinal mechanism is unfavorable, the body will be blocked inside and outside, the cancer toxin has no place to be released, emotional disorder and the supernatural power will leak out, then healthy qi deficiency can’t prevent cancer. Further connecting the theory of “Shaoyang” with the modern research progress, it can be found that abnormal autophagy,intestinal flora disorder, tumor angiogenesis and immune disorder may be the biological basis of intestinal cancer metastasis caused by unfavorable Shaoyang. It is helpful to prevent and treat the metastasis of colorectal cancer in consideration of “Shaoyang”.
占向阳 金敬云 李琦 刘慧. 从少阳理论探讨大肠癌转移[J]. 中国医药导报, 2021, 18(27): 121-124.
ZHAN Xiangyang JIN Jingyun LI Qi LIU Hui. Discussion on metastasis of colorectal cancer from Shaoyang theory. 中国医药导报, 2021, 18(27): 121-124.
[1] Zhang S,Sun K,Zheng R,et al. Cancer incidence and mortality in China,2015 [J]. Journal of the National Cancer Center,2020.
[2] Bray F,Ferlay J,Soerjomataram I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin,2018,68(6):394-424.
[3] Grothey A,Sobrero AF,Shields AF,et al. Duration of Adjuvant Chemotherapy for Stage Ⅲ Colon Cancer [J]. N Engl J Med,2018,378(13): 1177-1188.
[4] Gupta GP,Massagué J. Cancer metastasis:building a framework [J]. Cell,2006,127(4):679-695.
[5] Jia R,Liu N,Cai G,et al. Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage Ⅲ Colon Cancer:A Randomized,Double-Blind,Placebo-Controlled Clinical Trial [J]. Front Oncol,2021,11:618793.
[6] 张志聪.侣山堂类辩[M].南京:江苏科学技术出版社,1982:7.
[7] 杨越,刘宁宁,张程程,等.大肠癌转移的中医病机探讨[J].中华中医药学刊,2018,36(9):2214-2216.
[8] 邢玉亭,王静,刘少玉,等.杜怀棠教授应用大柴胡汤治疗大肠癌经验[J].世界中西医结合杂志,2020,15(5):860-862,918.
[9] 杨燕青,张兆州,李琦.李琦教授运用小柴胡汤合方辨治肿瘤[J].吉林中医药,2018,38(8):893-896.
[10] Rohatgi RA,Janusis J,Leonard D,et al. Beclin 1 regulates growth factor receptor signaling in breast cancer [J]. Oncogene,2015,34(42):5352-5362.
[11] 钱帅伟,罗艳蕊,漆正堂,等.细胞自噬的分子学机制及运动训练的调控作用[J].体育科学,2012,32(1):64-70.
[12] Ruocco N,Costantini S,Costantini M. Blue-Print Autophagy:Potential for Cancer Treatment [J]. Mar Drugs,2016,14(7):138.
[13] Lock R,Kenific CM,Leidal AM,et al. Autophagy- dependent production of secreted factors facilitates oncogenic RAS-driven invasion [J]. Cancer Discov,2014,4(4):466-479.
[14] Budisan L,Gulei D,Jurj A,et al. Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines-Possible Implications in New Therapeutic Strategies [J]. Int J Mol Sci,2019,20(5):1199.
[15] 陈海彬,周红光,李文婷,等.基于肠道菌群的结肠癌防治及与癌毒病机理论的关系[J].中华中医药杂志,2019, 34(12):5796-5800.
[16] 王赫,史新龙,李晶晶,等.肠道菌群与结直肠肿瘤关系的研究进展[J].中国普通外科杂志,2020,29(10):1261-1269.
[17] 朱建伟,冷玉琳,周秀娟,等.基于肠道菌群从气机升降理论探析糖尿病发病机制[J].中国实验方剂学杂志,2019, 25(21):189-195.
[18] 王睿,王霖,魏广义,等.黄芩素调节肠道菌群并改善小鼠化疗诱导性肠黏膜炎的作用及其机制[J].药学学报,2020,55(5):868-876.
[19] 刘世锋,罗玉霜,刘佩琳,等.黄芩提取物对人体肠道菌群及短链脂肪酸的影响[J].中国食物与营养,2021,27(1):49-53.
[20] Zhang Z,Shao S,Zhang Y,et al. Xiaoyaosan slows cancer progression and ameliorates gut dysbiosis in mice with chronic restraint stress and colorectal cancer xenografts [J]. Biomed Pharmacother,2020,132:110916.
[21] Sun W. Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy [J]. J Hematol Oncol,2012, 5(1):63-63.
[22] 周利红,伏杰,隋华,等.大肠癌血瘀证与非血瘀证患者血液流变学指标及促血管生成相关因子表达的差异性研究[J].上海中医药杂志,2019,53(5):25-30.
[23] 郁仁存.活血化瘀与肿瘤治疗[J].北京中医,1992,35(1):21-25.
[24] 于慧玲,麻春杰,盖聪.小柴胡汤对C6胶质瘤大鼠微血管密度和肿瘤细胞增殖活性的影响[J].中国老年学杂志,2014,34(11):3056-3058.
[25] 于慧玲,麻春杰,盖聪.小柴胡汤对C6胶质瘤大鼠ESM-1、VEGF表达的实验研究[J].中国实验诊断学,2014, 18(5):708-711.
[26] 李晓曼,刘量,吴媛媛,等.情志在肿瘤发生和发展中的作用[J].肿瘤,2019,39(12):1037-1042.
[27] Zhao Y,Jia Y,Shi T,et al. Depression Promotes Hepatocellular Carcinoma Progression through a Glucocorticoids Mediated Up-Regulation of PD-1 Expression in Tumor infiltrating NK Cells [J]. Carcinogenesis,2019.
[28] 姚嘉良,刘海涛,田建辉,等.从少阳为枢论治肝癌合并抑郁[J].中医学报,2021,36(2):289-292.
[29] 邵诗芸,张兆洲,王炎,等.小柴胡汤对压力应激性大肠癌小鼠NF-κB /NLRP3信号通路的影响[J].上海中医药杂志,2020,54(S1):132-136,141.
[30] 韩增祥,李悦,禹雯琦,等.肿瘤相关巨噬细胞在结肠癌中研究进展及治疗前景[J].辽宁中医药大学学报,2019, 21(5):79-82.
[31] 阮志燕,陈庆凤,赖满香.盐酸芬戈莫德对结肠癌小鼠肿瘤免疫相关因子的影响[J].中国医药科学,2019,9(5):14-17.
[32] 韩增祥.基于β肾上腺素通路调控的TAMs极化研究逍遥散抑制结肠癌转移的作用[D].上海:上海中医药大学,2019.
[33] 赵璐,倪依群.逍遥散治疗晚期结直肠癌肝气郁结证的临床研究[J].中医药导报,2019,25(5):110-112,119.